Last reviewed · How we verify
Iridocyclitis
Approved treatments
- Lotemax · Bausch Health
- Fml · AbbVie
- Klaron · Merck & Co.
- Medrifar · AbbVie
- Cortone
- Lotemax · Tufts Medical Center
- Decadron · Generic (originally Merck)
- Cortef · Generic (originally Merck/Upjohn)
- Flarex · Harrow Health
- Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
- scopolamin · University Hospital, Angers
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Iridocyclitis patent landscape — cliff calendar, originator estates, attackable patents
- Iridocyclitis treatment landscape brief
- Iridocyclitis treatment updates RSS
Frequently asked questions about Iridocyclitis
What drugs treat Iridocyclitis?
Tracked treatments include Lotemax, Fml, Klaron, Medrifar, Cortone, Decadron, Cortef, Flarex.
What is the treatment for Iridocyclitis?
Standard treatment for Iridocyclitis includes Lotemax, Fml, Klaron, Medrifar, Cortone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Iridocyclitis patent cliff · Iridocyclitis CI report
- Treatment: Lotemax · Bausch Health
- Treatment: Fml · AbbVie
- Treatment: Klaron · Merck & Co.
- Treatment: Medrifar · AbbVie
- Treatment: Cortone
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing